2013 American Transplant Congress

Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients

K. Kutsunai, K. Iwadoh, T. Horibe, Y. Ogawa, K. Kai, T. Murakami, I. Koyama, I. Nakajima, S. Fuchinoue

Should All Type 1 Diabetic Patients (T1DM) Undergo Cardiac Angiography for Transplant Evaluation?

A. Elsanjak, A. Selek, V. Vidyasagar, M. Mohamed, J. Odorico, A. Djamali, G. Leverson, H. Sollinger, J. Pirsch, D. Kaufman

Should National Policymakers Augment Marginal Liver Transplants: A Population Game Approach

Should Repeat HLA Mismatches Be Avoided in Lung ReTransplants?

M. Askar, P. Reville, J. Daghstani, L. Klingman, K. McCurry, M. Budev

SHROOM3 Is a Predictor of Fibrosis in CAN and CKD

M. Menon, P. Chuang, Y. Luan, W. Zhang, C. Woytovich, Z. Li, P. O'Connell, L. Gallon, R. Colvin, B. Schroppel, J. He, B. Murphy

Significance of Non-Dipping Blood Pressure Profile on Renal Allograft Function

E. Anyaegbu, J. Zheng, V. Dharnidharka

Significance of Preformed Donor Specific Antibodies (DSA) Detected by Highly Sensitive Solid Phase Assays: Prediction of Acute Antibody Mediated Rejection (AMR)

D. Kannabhiran, J. Lee, R. Friedlander, D. Epstein, T. Muthukumar, J. Lee, M. Aull, A. Watkins, S. Kapur, V. Sharma, M. Suthanthiran, D. Dadhania

Significance of Time-Zero Biopsy Findings for Deceased Donor Kidney Transplantation, The

A. Lee, M. Kim, H. Jeong, D. Joo, S. Lee, B. Kim, K. Huh, Y. Kim, K. Park

Significant Deficiencies in Postoperative Handoffs Revealed in a Comprehensive Assessment of Living Donor Liver Transplantation Systems and Processes of Care

L. McElroy, J. Holl, A. Daud, M. Abecassis, D. Woods, D. Ladner

Significant Impact of Prolonged Brain Death Duration on Patient Survival after Kidney Transplantation

A. Weissenbacher, R. Oberhuber, S. Weiss, B. Cardini, C. Bösmüller, S. Schneeberger, J. Pratschke, R. Öllinger